Congenital Diaphragmatic Hernia Clinical Trial
Official title:
A Machine Learning Approach to Predict Pulmonary Hypertension in Newborns With Congenital Diaphragmatic Hernia: a Pilot Study
Congenital Diaphragmatic Hernia (CDH) is characterized by an incomplete diaphragm formation, resulting in poor lung development (pulmonary hypoplasia), associated with altered vascularization of the lung (pulmonary hypertension), with respiratory and cardiovascular insufficiency at birth. Mortality and morbidity are extremely variable. Several efforts have been done to identify possible prenatal and postnatal indicators which could accurately predict patients' prognosis and to promote an individualized management. However, to date the accuracy of these factors with respect to the prediction of survival and disease severity still has limits. In the last years, there has been an impressive development of new research methodologies based on the artificial intelligence, also in the neonatal field. The Machine Learning (ML) method explores the possibility of building algorithms starting from the acquisition of relevant clinical data, and using them to make predictions or take decisions. Nevertheless, the ML method has never been applied to predict patient's outcome in newborns with CDH so far. Moreover, with the available tools, a reliable prediction on patient's risk of developing severe postnatal PH is not feasible. Our hypothesis is that the use of ML approach, based on multivariate analysis of different clinical pre- and postnatal variables, could allow the development of algorithms able to accurately predict patient's outcome.
The investigators will collect clinical and instrumental data regarding prenatal history as well as the medical and surgical postnatal course. In particular, the investigators will record data from a prenatal ultrasound performed between 25+0 and 30+6 weeks of gestation (before "Fetoscopic Endotracheal Occlusion" (FETO) procedure, in case of prenatal treatment): estimated fetal weight (EFW), amniotic fluid, Doppler velocimetry of umbilical artery, defect side, herniated organs, observed/expected lung-to-head ratio tracing (O/E LHR%), grading of hernia severity, Doppler velocimetry of contralateral pulmonary artery. Gestational age at diagnosis, details about FETO procedure, and the course of pregnancy will be also recorded. On fetal MRI, the investigators will calculate: observed/expected total fetal lung volume (O/E TFLV%), percentage of liver herniation (%LH), signal intensity of lung and liver on T2 sequences, mediastinal shift angle, apparent diffusion coefficient (ADC) on diffusion-weighted sequences (DWI). The radiographic pulmonary area will be calculated on digital chest x-ray performed within 24 hours after birth, by tracing the perimeter of the lung outlined by the rib cage and the diaphragm, excluding the mediastinal structures and the herniated organs. Regarding the neonatal course, the investigators will focus on pulmonary hypertensive status, need for ECMO, and deaths. In particular, pulmonary hypertension will be evaluated based on clinical parameters (such as systemic pressure, heart rate, oxygen saturation, and oxygen supplementation, inotropic drugs, vasopressors, pulmonary vasodilators) as well as echocardiographic parameters (systolic pulmonary artery pressure (PAPs) from tricuspid valve regurgitation, mean pulmonary artery pressure from pulmonary valve regurgitation, pulmonary artery flow, characteristics of the interventricular sept, shunts, cardiac anomalies). Echocardiograms in our NICU are performed bedside throughout the hospital stay. The investigators will consider one exam per day from birth to 48 hours after surgery, one exam per week in the following 4 weeks, one exam per months until discharge. Other relevant data, like neurologic complications, metabolic disorders or infections, will be recorded as well. Finally, the investigators will record data regarding the surgical course: day of intervention, type of surgical repair, use of patch, intra- or post-operative complications. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05100693 -
Smart Removal for Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT05450653 -
Trial of FETO for Severe Congenital Diaphragmatic Hernia
|
N/A | |
Terminated |
NCT04140669 -
Automated Myocardial Performance Index Using Samsung HERA W10
|
||
Recruiting |
NCT05201144 -
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
|
Phase 2 | |
Not yet recruiting |
NCT06281717 -
Fetal Endotracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT04429750 -
Intact Cord Resuscitation in CDH
|
N/A | |
Recruiting |
NCT03750266 -
3D Animation and Models to Aid Management of Fetal CDH
|
||
Not yet recruiting |
NCT05421676 -
Fetal Endoscopic Tracheal Occlusion for CDH (CDH)
|
N/A | |
Completed |
NCT01243229 -
Genetic Analysis of Congenital Diaphragmatic Disorders
|
||
Recruiting |
NCT04583644 -
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
|
N/A | |
Completed |
NCT03314233 -
Delayed Cord Clamping for Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT04114578 -
Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia
|
||
Completed |
NCT03666767 -
Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
|
||
Recruiting |
NCT02986087 -
Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT03674372 -
Fetoscopic Endoluminal Tracheal Occlusion
|
N/A | |
Active, not recruiting |
NCT05839340 -
Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias
|
N/A | |
Enrolling by invitation |
NCT05962346 -
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
|
N/A | |
Withdrawn |
NCT04186039 -
Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations
|
N/A | |
Unknown status |
NCT01302977 -
Fetal Tracheal Occlusion in Severe Diaphragmatic Hernia: a Randomized Trial
|
Phase 2 | |
Recruiting |
NCT03179371 -
Proteomic Profiling for Congenital Diaphragmatic Hernia
|